IRIDEX Corp (IRIX) income statement
IRIXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends January 3
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Oct 3, 2026Last filing: 10-Q on Nov 17, 2026Score 8/30
$0.50−0.20 (-28.53%)
Close on Nov 18, 2026Market cap $8.78MP/E –Yield –
IRIDEX Corp income statement
Ratios
Latest available, balances at Oct 3, 2026
Profitability, TTM
- Gross margin
- 38.2%
- Operating margin
- -5.1%
- Net margin
- -6.9%
- Return on equity, FY2025
- -126.4%
Financial strength
- Current ratio
- 1.76
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 28.3%
Valuation
- P/E ratio
- –
- Price to sales
- 0.18
- Price to book
- 3.34
- Dividend yield
- –
See a number that looks wrong?